CARNA BIOSCIENCES, INC. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 436 JPY | +0,23% |
|
0,00% | -16,48% |
Totale waarde
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 9.122 | 24.246 | 15.031 | 14.666 | 7.390 | 8.950 |
| Bedrijfswaarde 1 | 8.452 | 20.058 | 11.160 | 11.388 | 4.310 | 6.243 |
| K/w-verhouding | -7,2 x | 28,5 x | -13,4 x | -26,2 x | -5,25 x | -7,61 x |
| Dividendrendement | - | - | - | - | - | - |
| Marktkapitalisatie/omzet | 12,1 x | 7,56 x | 13,3 x | 7,27 x | 5,33 x | 5,51 x |
| Bedrijfswaarde/omzet | 11,2 x | 6,25 x | 9,85 x | 5,65 x | 3,11 x | 3,84 x |
| Bedrijfswaarde/EBITDA | -7,46 x | 20,3 x | -10,7 x | -22,2 x | -3,48 x | -5,77 x |
| Bedrijfswaarde/FCF | -10,6 x | 17,9 x | -11,3 x | -7,85 x | -11,8 x | -4,84 x |
| FCF Yield | -9,45% | 5,58% | -8,87% | -12,7% | -8,46% | -20,7% |
| Price to Book | 10,3 x | 6,42 x | 3,93 x | 3,4 x | 2,03 x | 2,31 x |
| Aantal aandelen (in duizenden) | 10.136 | 11.421 | 12.402 | 13.308 | 14.211 | 17.145 |
| Referentieprijs 2 | 900,0 | 2.123 | 1.212 | 1.102 | 520,0 | 522,0 |
| Datum van publicatie | 27/03/19 | 27/03/20 | 26/03/21 | 25/03/22 | 27/03/23 | 27/03/24 |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Omzet 1 | 754 | 3.207 | 1.133 | 2.017 | 1.386 | 1.625 |
| EBITDA 1 | -1.133 | 987 | -1.045 | -512 | -1.237 | -1.082 |
| Bedrijfsresultaat (EBIT) 1 | -1.145 | 978 | -1.057 | -531 | -1.270 | -1.117 |
| Operationele Marge | -151,86% | 30,5% | -93,29% | -26,33% | -91,63% | -68,74% |
| Resultaat voor belastingen (EBT) 1 | -1.207 | 912 | -1.103 | -533 | -1.323 | -1.130 |
| Nettowinst (verlies) 1 | -1.210 | 828 | -1.111 | -534 | -1.349 | -1.152 |
| Nettomarge | -160,48% | 25,82% | -98,06% | -26,47% | -97,33% | -70,89% |
| WPA 2 | -125,0 | 74,51 | -90,33 | -42,06 | -99,06 | -68,57 |
| Free Cash Flow 1 | -798,5 | 1.120 | -990 | -1.451 | -364,5 | -1.290 |
| FCF-marge | -105,9% | 34,93% | -87,38% | -71,96% | -26,3% | -79,36% |
| Kasstroomconversie (ebitda) | - | 113,5% | - | - | - | - |
| Kasstroomconversie (nettowinst) | - | 135,3% | - | - | - | - |
| Dividend per aandeel | - | - | - | - | - | - |
| Datum van publicatie | 27/03/19 | 27/03/20 | 26/03/21 | 25/03/22 | 27/03/23 | 27/03/24 |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2020 S1 | 2021 S1 | 2021 Q3 | 2022 Q1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 579 | 430 | 206 | 554 | 839 | 256 | 226 | 500 | 211 | 180 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | -375 | -777 | -392 | 1 | -312 | -441 | -505 | -863 | -338 | -416 |
| Operationele Marge | -64,77% | -180,7% | -190,29% | 0,18% | -37,19% | -172,27% | -223,45% | -172,6% | -160,19% | -231,11% |
| Resultaat voor belastingen (EBT) 1 | -396 | -780 | -397 | -10 | -349 | -429 | -513 | -869 | -338 | -397 |
| Nettowinst (verlies) 1 | -397 | -776 | -402 | -15 | -359 | -436 | -519 | -885 | -345 | -398 |
| Nettomarge | -68,57% | -180,47% | -195,15% | -2,71% | -42,79% | -170,31% | -229,65% | -177% | -163,51% | -221,11% |
| WPA 2 | -32,60 | -62,50 | -31,74 | -1,120 | -26,53 | -32,03 | -32,78 | -53,81 | -19,93 | -23,27 |
| Dividend per aandeel | - | - | - | - | - | - | - | - | - | - |
| Datum van publicatie | 7/08/20 | 6/08/21 | 8/11/21 | 10/05/22 | 5/08/22 | 7/11/22 | 10/05/23 | 7/08/23 | 7/11/23 | 10/05/24 |
1JPY in Miljoen2JPY
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | - |
| Nettokaspositie 1 | 670 | 4.188 | 3.871 | 3.278 | 3.080 | 2.707 |
| Hefboom (schuld/ebitda) | - | - | - | - | - | - |
| Free Cash Flow 1 | -799 | 1.120 | -990 | -1.451 | -365 | -1.290 |
| ROE (netto-inkomsten/eigen vermogen) | -107% | 34,9% | -28,9% | -13,1% | -33,9% | -30,7% |
| ROA (netto-inkomsten/totale activa) | -36,1% | 17,1% | -12,9% | -6,46% | -16,4% | -16,2% |
| Totale activa 1 | 3.348 | 4.840 | 8.586 | 8.260 | 8.241 | 7.108 |
| Nettoactief per aandeel 2 | 87,50 | 331,0 | 308,0 | 324,0 | 256,0 | 226,0 |
| Cashflow per aandeel 2 | 134,0 | 422,0 | 347,0 | 287,0 | 238,0 | 169,0 |
| Capex 1 | 58 | 41 | 64 | 41 | 126 | 11 |
| Capex/omzet | 7,69% | 1,28% | 5,65% | 2,03% | 9,09% | 0,68% |
| Datum van publicatie | 27/03/19 | 27/03/20 | 26/03/21 | 25/03/22 | 27/03/23 | 27/03/24 |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Historische marktkapitalisatie/EBITDA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -16,48% | 48,05 mln. | |
| +33,63% | 50,85 mld. | |
| -0,09% | 42,82 mld. | |
| +49,62% | 42,03 mld. | |
| -4,96% | 29,55 mld. | |
| +11,18% | 26,11 mld. | |
| -21,95% | 19,13 mld. | |
| +8,61% | 13,05 mld. | |
| +28,31% | 12,16 mld. | |
| +24,73% | 12,08 mld. |
- Beurs
- Aandelen
- Koers 4572
- Financiën Carna Biosciences, Inc.
